JPH04301765A - Immunological measuring method - Google Patents
Immunological measuring methodInfo
- Publication number
- JPH04301765A JPH04301765A JP6712891A JP6712891A JPH04301765A JP H04301765 A JPH04301765 A JP H04301765A JP 6712891 A JP6712891 A JP 6712891A JP 6712891 A JP6712891 A JP 6712891A JP H04301765 A JPH04301765 A JP H04301765A
- Authority
- JP
- Japan
- Prior art keywords
- water
- analytical element
- antibody
- antigen
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title description 27
- 230000001900 immune effect Effects 0.000 title 1
- 239000000427 antigen Substances 0.000 claims abstract description 28
- 108091007433 antigens Proteins 0.000 claims abstract description 28
- 102000036639 antigens Human genes 0.000 claims abstract description 28
- 102000004190 Enzymes Human genes 0.000 claims abstract description 27
- 108090000790 Enzymes Proteins 0.000 claims abstract description 27
- 239000000126 substance Substances 0.000 claims abstract description 27
- 239000000463 material Substances 0.000 claims abstract description 25
- 238000006243 chemical reaction Methods 0.000 claims abstract description 18
- 239000002250 absorbent Substances 0.000 claims abstract description 9
- 239000011358 absorbing material Substances 0.000 claims description 18
- 238000003018 immunoassay Methods 0.000 claims description 18
- 230000008105 immune reaction Effects 0.000 claims description 13
- 238000004458 analytical method Methods 0.000 claims description 7
- 230000009471 action Effects 0.000 claims description 5
- 230000001747 exhibiting effect Effects 0.000 claims description 2
- 239000000835 fiber Substances 0.000 abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 8
- 239000007788 liquid Substances 0.000 abstract description 7
- 230000002745 absorbent Effects 0.000 abstract description 3
- 230000003053 immunization Effects 0.000 abstract description 3
- 238000002649 immunization Methods 0.000 abstract 2
- 238000002791 soaking Methods 0.000 abstract 2
- 239000010410 layer Substances 0.000 description 40
- 229940088598 enzyme Drugs 0.000 description 23
- 239000000243 solution Substances 0.000 description 15
- 239000000758 substrate Substances 0.000 description 13
- 108010010803 Gelatin Proteins 0.000 description 12
- 229920000159 gelatin Polymers 0.000 description 12
- 239000008273 gelatin Substances 0.000 description 12
- 235000019322 gelatine Nutrition 0.000 description 12
- 235000011852 gelatine desserts Nutrition 0.000 description 12
- -1 prosthetic groups Substances 0.000 description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 11
- 229920002401 polyacrylamide Polymers 0.000 description 8
- 239000002245 particle Substances 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 229920000936 Agarose Polymers 0.000 description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 6
- 239000008187 granular material Substances 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- 108090001008 Avidin Proteins 0.000 description 5
- 239000004793 Polystyrene Substances 0.000 description 5
- 229920002678 cellulose Polymers 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 229920002223 polystyrene Polymers 0.000 description 5
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 4
- 108010090804 Streptavidin Proteins 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 102000005936 beta-Galactosidase Human genes 0.000 description 4
- 108010005774 beta-Galactosidase Proteins 0.000 description 4
- 238000009739 binding Methods 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 238000002372 labelling Methods 0.000 description 4
- 239000008108 microcrystalline cellulose Substances 0.000 description 4
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 4
- 229940016286 microcrystalline cellulose Drugs 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 229920001778 nylon Polymers 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 229920000139 polyethylene terephthalate Polymers 0.000 description 4
- 239000005020 polyethylene terephthalate Substances 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 241000124008 Mammalia Species 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 229920000297 Rayon Polymers 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000001042 affinity chromatography Methods 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 239000005515 coenzyme Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000036046 immunoreaction Effects 0.000 description 3
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 3
- 238000000691 measurement method Methods 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 2
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 2
- PTHCMJGKKRQCBF-UHFFFAOYSA-N Cellulose, microcrystalline Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC)C(CO)O1 PTHCMJGKKRQCBF-UHFFFAOYSA-N 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 102000010911 Enzyme Precursors Human genes 0.000 description 2
- 108010062466 Enzyme Precursors Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000005909 Kieselgur Substances 0.000 description 2
- 108090001090 Lectins Proteins 0.000 description 2
- 102000004856 Lectins Human genes 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 229920002978 Vinylon Polymers 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000010425 asbestos Substances 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 235000009120 camo Nutrition 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 235000005607 chanvre indien Nutrition 0.000 description 2
- 238000006757 chemical reactions by type Methods 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 239000002532 enzyme inhibitor Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000003365 glass fiber Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 239000011487 hemp Substances 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229910000464 lead oxide Inorganic materials 0.000 description 2
- 239000002523 lectin Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 201000000050 myeloid neoplasm Diseases 0.000 description 2
- YEXPOXQUZXUXJW-UHFFFAOYSA-N oxolead Chemical compound [Pb]=O YEXPOXQUZXUXJW-UHFFFAOYSA-N 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000002964 rayon Substances 0.000 description 2
- 229910052895 riebeckite Inorganic materials 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 229920003002 synthetic resin Polymers 0.000 description 2
- 239000000057 synthetic resin Substances 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 210000002268 wool Anatomy 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- VLARLSIGSPVYHX-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 6-(2,5-dioxopyrrol-1-yl)hexanoate Chemical compound O=C1CCC(=O)N1OC(=O)CCCCCN1C(=O)C=CC1=O VLARLSIGSPVYHX-UHFFFAOYSA-N 0.000 description 1
- AUTOLBMXDDTRRT-JGVFFNPUSA-N (4R,5S)-dethiobiotin Chemical compound C[C@@H]1NC(=O)N[C@@H]1CCCCCC(O)=O AUTOLBMXDDTRRT-JGVFFNPUSA-N 0.000 description 1
- ZKGIQGUWLGYKMA-UHFFFAOYSA-N 1,2-bis(ethenylsulfonyl)ethane Chemical compound C=CS(=O)(=O)CCS(=O)(=O)C=C ZKGIQGUWLGYKMA-UHFFFAOYSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 108010006591 Apoenzymes Proteins 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 101000950981 Bacillus subtilis (strain 168) Catabolic NAD-specific glutamate dehydrogenase RocG Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 101001011741 Bos taurus Insulin Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000002464 Galactosidases Human genes 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 102000016901 Glutamate dehydrogenase Human genes 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 239000006173 Good's buffer Substances 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010029719 Nonspecific reaction Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000577979 Peromyscus spicilegus Species 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 239000012637 allosteric effector Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000003453 ammonium sulfate precipitation method Methods 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229920006318 anionic polymer Polymers 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- IXIBAKNTJSCKJM-BUBXBXGNSA-N bovine insulin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 IXIBAKNTJSCKJM-BUBXBXGNSA-N 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 125000000068 chlorophenyl group Chemical group 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- QKSIFUGZHOUETI-UHFFFAOYSA-N copper;azane Chemical compound N.N.N.N.[Cu+2] QKSIFUGZHOUETI-UHFFFAOYSA-N 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000003028 enzyme activity measurement method Methods 0.000 description 1
- KXVGTQFNYXBBHD-UHFFFAOYSA-N ethenyl acetate;pyrrolidin-2-one Chemical compound CC(=O)OC=C.O=C1CCCN1 KXVGTQFNYXBBHD-UHFFFAOYSA-N 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 210000004754 hybrid cell Anatomy 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229960003151 mercaptamine Drugs 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000002557 mineral fiber Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- UYDLBVPAAFVANX-UHFFFAOYSA-N octylphenoxy polyethoxyethanol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCOCCOCCOCCO)C=C1 UYDLBVPAAFVANX-UHFFFAOYSA-N 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920002006 poly(N-vinylimidazole) polymer Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000003232 water-soluble binding agent Substances 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
Landscapes
- Automatic Analysis And Handling Materials Therefor (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Sampling And Sample Adjustment (AREA)
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は、免疫学的測定法に関す
るものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an immunoassay method.
【0002】0002
【発明の背景】生物学的流体試料中に極微量含有される
物質を検出する方法として、各種の分析法が開発されて
来ている。この分析法の一つとして、免疫反応をその原
理とするものがある。そして、この原理を用いた測定法
として種々のものが開発され、精度の高いものとして知
られている。すなわち、BersonとYallowが
放射性同位元素Iで標識したウシインシュリンと糖尿病
患者血清中の抗インシュリン抗体を用いて血清中のイン
シュリンを測定することに成功して以来、ラジオアイソ
トープを用いた免疫測定法が広く用いられて来た。そし
て、これ以後、標識物質として放射性同位元素以外のも
のも種々開発されて来た。例えば、酵素、酵素基質、補
酵素、酵素阻害物質、バクテリオファージ、循環反応体
、金属及び有機金属の錯体、有機補欠分子族、化学発光
性反応体及び螢光性分子等が挙げられる。BACKGROUND OF THE INVENTION Various analytical methods have been developed for detecting trace amounts of substances contained in biological fluid samples. One of these analytical methods is based on immune reactions. Various measurement methods using this principle have been developed and are known to be highly accurate. That is, since Berson and Yallow succeeded in measuring insulin in serum using bovine insulin labeled with radioisotope I and anti-insulin antibodies in the serum of diabetic patients, immunoassay methods using radioisotopes have been developed. It has been widely used. Since then, various labeling substances other than radioactive isotopes have been developed. Examples include enzymes, enzyme substrates, coenzymes, enzyme inhibitors, bacteriophages, cycling reactants, metal and organometallic complexes, organic prosthetic groups, chemiluminescent reactants, fluorescent molecules, and the like.
【0003】このような免疫学的測定法は、均一免疫測
定法と非均一免疫測定法に大別される。すなわち、抗原
抗体反応生成物(Bound体)と非反応物(Free
体)との分離(B/F分離)が必要な非均一免疫測定法
と、B/F分離の必要のない均一免疫測定法とに大別さ
れる。このうち、測定対象物質が高分子である場合には
、B/F分離が必要な非均一免疫測定法が利用されてい
る。[0003] Such immunoassay methods are broadly classified into homogeneous immunoassay methods and non-uniform immunoassay methods. That is, the antigen-antibody reaction product (Bound body) and the non-reactant (Free
They are broadly divided into non-homogeneous immunoassay methods that require separation from the body (B/F separation) and homogeneous immunoassay methods that do not require B/F separation. Among these, when the substance to be measured is a polymer, a non-uniform immunoassay method that requires B/F separation is used.
【0004】ところで、この非均一免疫測定法は洗浄操
作、試薬の調整が必要であること、標識物質、基質、反
応停止液等の添加が必要であることから操作が煩雑であ
ること等の問題がある。これらの問題点に対して各種の
技術が提案されている。例えば、特開昭64−6386
3号公報、特開昭64−63864号公報、特開平2−
8344号公報においては、乾式分析素子を用いること
により操作性はかなり簡便になっているものの、簡便性
に対する要求は高まる一方であり、改善が待たれている
。[0004] However, this non-uniform immunoassay method has problems such as complicated operations because it requires washing operations, preparation of reagents, and addition of labeling substances, substrates, reaction stop solutions, etc. There is. Various techniques have been proposed to address these problems. For example, JP-A-64-6386
Publication No. 3, JP-A-64-63864, JP-A-2-
Although the operability of the method disclosed in Japanese Patent No. 8344 is considerably simplified by using a dry analytical element, the demand for simplicity continues to increase, and improvements are awaited.
【0005】[0005]
【発明の開示】本発明の目的は、液体試料中の特定成分
を、簡便な操作で、再現性良く正確に定量できる技術を
提供することである。この本発明の目的は、容器中で免
疫反応を行わせた後、この容器中の反応液に毛細管現象
を発揮できる吸水性素材を浸け、この吸水性素材を介し
て標識体を吸水性素材に接合された分析素子に移行させ
、標識体を分析素子で測定することにより試料中の特定
成分を分析することを特徴とする免疫学的測定法によっ
て達成される。DISCLOSURE OF THE INVENTION An object of the present invention is to provide a technique that allows accurate quantification of specific components in a liquid sample with good reproducibility using simple operations. The purpose of the present invention is to perform an immune reaction in a container, then immerse a water-absorbing material capable of exhibiting capillary action in the reaction solution in the container, and transfer the label to the water-absorbing material through this water-absorbing material. This is achieved by an immunoassay method characterized by analyzing a specific component in a sample by transferring the labeled substance to a bonded analytical element and measuring the labeled substance with the analytical element.
【0006】又、固定化担体に固定化された固定化抗体
(又は抗原)、酵素標識抗体(又は抗原)及び試料中の
抗原(又は抗体)による免疫反応を容器中で行わせた後
、分析素子と接合された吸水性素材を反応液に浸け、吸
水性素材の毛細管現象により遊離の酵素標識抗体(又は
抗原)を分析素子に移行させ、その後前記分析素子を取
り、標識酵素を分析素子で測定することにより試料中の
抗原(又は抗体)を分析することを特徴とする免疫学的
測定法によって達成される。[0006] Also, after an immune reaction is performed in a container with the immobilized antibody (or antigen) immobilized on the immobilization carrier, the enzyme-labeled antibody (or antigen), and the antigen (or antibody) in the sample, analysis is performed. The water-absorbent material bonded to the element is immersed in the reaction solution, and the free enzyme-labeled antibody (or antigen) is transferred to the analytical element by capillary action of the water-absorbent material.Then, the analytical element is removed, and the labeled enzyme is transferred to the analytical element. This is achieved by an immunoassay method characterized by analyzing antigens (or antibodies) in a sample by measuring them.
【0007】以下、本発明をさらに詳しく説明する。本
発明において、試料としてはあらゆる形態の溶液、コロ
イド溶液などが使用しうるが、好ましくは生物由来の試
料、例えば血液、血漿、血清、脳脊髄液、唾液、羊水、
乳、尿、汗、肉汁等が挙げられる。免疫反応において用
いられる標識物質としては、例えば酵素、酵素基質、酵
素及び酵素前駆体の活性を変化させる物質(酵素阻害物
質、補欠分子族、補酵素)、酵素前駆体、アポ酵素、螢
光物質などが挙げられるが、例えばβ−D−ガラクトシ
ダーゼ、アルカリホスフォダーゼ、ペルオキシダーゼ、
グルコースオキシダーゼ、グルタメートデヒドロゲナー
ゼ、アミラーゼ等の酵素が好ましく、これらの酵素を標
識物質とする場合、酵素反応系、発色系は公知のものを
使用できる。具体的には、特開昭61−292060号
公報、特開昭62−90539号公報、特開昭63−1
31062号公報、特開昭63−45562号公報、特
願昭63−219893号明細書に記載の物質(物質群
)が挙げられるが、これらに限定されるものではない。
そして、標識物質の抗体(抗原)への結合は、当業者間
で知られている公知の試薬と方法で行うことができ、例
えば石川 栄治、河合忠、宮井 潔 編「酵素免
疫測定法(第2版)、医学書院、1978年」や日本臨
床病理学会編「臨床病理」臨時増刊特集第53号「臨床
検査の為のイムノアッセイ−技術と応用−、臨床病理刊
行会、1983年」などに記載された方法を参考にする
ことができる。The present invention will be explained in more detail below. In the present invention, any form of solution, colloidal solution, etc. can be used as the sample, but samples of biological origin are preferably used, such as blood, plasma, serum, cerebrospinal fluid, saliva, amniotic fluid,
Examples include milk, urine, sweat, meat juice, etc. Examples of labeling substances used in immune reactions include enzymes, enzyme substrates, substances that change the activity of enzymes and enzyme precursors (enzyme inhibitors, prosthetic groups, coenzymes), enzyme precursors, apoenzymes, and fluorescent substances. Examples include β-D-galactosidase, alkaline phosphodase, peroxidase,
Enzymes such as glucose oxidase, glutamate dehydrogenase, and amylase are preferred, and when these enzymes are used as labeling substances, known enzyme reaction systems and coloring systems can be used. Specifically, JP-A-61-292060, JP-A-62-90539, JP-A-63-1
Examples include substances (substance groups) described in Japanese Patent Application Laid-Open No. 31062, Japanese Patent Application Laid-Open No. 63-45562, and Japanese Patent Application No. 63-219893, but are not limited thereto. The binding of the labeled substance to the antibody (antigen) can be carried out using known reagents and methods known to those skilled in the art. 2nd edition), Igaku Shoin, 1978" and "Immunoassays for Clinical Tests - Techniques and Applications -, Clinical Pathology Publications Society, 1983", Special Special Issue No. 53 of "Clinical Pathology" edited by the Japanese Society of Clinical Pathology, etc. You can refer to the method provided.
【0008】本発明の免疫反応で使用される抗体は、そ
の由来を特に限定されるものではなく、哺乳動物等に抗
原を投与、免疫して得られる抗血清、腹水液をそのまま
か、あるいは従来公知の方法である硫酸ナトリウム沈澱
法、硫酸アンモニウム沈澱法、セファデックスゲルによ
るゲル濾過法、イオン交換セルロースクロマトグラフィ
法、電気泳動法等(右田俊介偏「免疫化学」中山書店p
p74ないし88参照)で精製して用いることができる
。あるいは、抗原で感染した哺乳動物など(例えばマウ
ス)の脾臓細胞や骨髄腫細胞(ミエローマ)から雑種細
胞(ハイブリドーマ)を得てモノクローナル抗体を作成
し、これを特定成分と特異的に結合しうる物質として使
用すると特異性が向上し、好ましい。又、これらの抗体
はIgG、IgM、IgA、IgD、IgE各分画を用
いることができ、或いはこれらの抗体を酵素処理してF
ab、Fab’又はF(ab’)2 といった活性抗体
フラグメントにして使用しても良い。さらに、これらの
抗体は単一で使用しても、複数の抗体を組み合わせて使
用しても良い。[0008] The origin of the antibody used in the immune reaction of the present invention is not particularly limited. Antiserum obtained by administering and immunizing a mammal with an antigen, ascites fluid as it is, or conventional Known methods such as sodium sulfate precipitation method, ammonium sulfate precipitation method, gel filtration method using Sephadex gel, ion exchange cellulose chromatography method, electrophoresis method, etc. (Shunsuke Migita, "Immunochemistry", Nakayama Shoten p.
(see pages 74 to 88). Alternatively, hybrid cells (hybridoma) are obtained from spleen cells or myeloma cells (myeloma) of a mammal (e.g. mouse) infected with an antigen, and a monoclonal antibody is created, which is then used as a substance that can specifically bind to a specific component. It is preferable to use it as the specificity improves. Furthermore, these antibodies can be used in IgG, IgM, IgA, IgD, and IgE fractions, or these antibodies can be treated with enzymes to produce F.
It may also be used in the form of active antibody fragments such as ab, Fab' or F(ab')2. Furthermore, these antibodies may be used alone or in combination.
【0009】本発明の免疫測定方法による反応型式とし
ては、競合法、2抗体法、サンドイッチ法などが挙げら
れるが、特に限定はされない。又、他の生物活性物質(
例えば、ビオチン、アビジン)を利用した免疫測定方法
も適用できる。本発明においては、試料中の特定成分を
測定する反応型式として免疫反応を挙げているが、免疫
反応に準ずる生物活性を示す物質の特異反応(本明細書
では、この特異反応も免疫反応に包含)を利用すること
も可能である。この特異的に結合する物質の組み合わせ
としては、次のようなものが挙げられる。[0009] Reaction types according to the immunoassay method of the present invention include a competitive method, a two-antibody method, a sandwich method, etc., but are not particularly limited. Also, other biologically active substances (
For example, immunoassay methods using biotin, avidin) can also be applied. In the present invention, an immune reaction is mentioned as a reaction type for measuring a specific component in a sample, but a specific reaction of a substance that exhibits biological activity similar to an immune reaction (in this specification, this specific reaction is also included in the immune reaction). ) can also be used. Examples of combinations of substances that specifically bind include the following.
【0010】酵素と基質(生成物)
酵素と阻害剤
酵素と補欠分子族
酵素と補酵素
酵素とアロステリックエフェクター
抗体と抗原
抗体とプロテインA
レクチンと多糖類
レクチンと糖タンパク質
核酸と相補性の塩基配列
核酸とヒストン
核酸と核酸
核酸とポリメラーゼ
ホルモンと受容体
ピオチンとアビジン(ストレプトアビジン)ビオチシン
とアビジン(ストレプトアビジン)デスチオビオチンと
アビジン(ストレプトアビジン)オキシビオチンとアビ
ジン(ストレプトアビジン)本発明で使用される抗原は
特異抗体と反応するものであり、ハプテン及びその誘導
体を含有する。Enzyme and Substrate (Product) Enzyme and Inhibitor Enzyme and Prosthetic Group Enzyme and Coenzyme Enzyme and Allosteric Effector Antibody and Antigen Antibody and Protein A Lectin and Polysaccharide Lectin and Glycoprotein Nucleic Acid and Complementary Base Sequence Nucleic Acid and Histone Nucleic Acids and Nucleic Acids Nucleic Acids and Polymerases Hormones and Receptors Pyotin and Avidin (Streptavidin) Bioticin and Avidin (Streptavidin) Desthiobiotin and Avidin (Streptavidin) Oxybiotin and Avidin (Streptavidin) Antigens Used in the Invention reacts with specific antibodies and contains haptens and derivatives thereof.
【0011】抗体(又は抗原)は不溶化担体に固定化さ
れる。不溶化担体としては粒状体、例えば大きさが2m
m以下の粒状体が好ましい。不溶化担体(微粒子)の材
料としては、アガロース、セルロース、架橋デキストラ
ン、ポリアクリルアミド、セルロース、微結晶セルロー
ス、架橋アガロース、架橋ポリアクリルアミド、ガラス
、シリカゲル、ケイ藻土、二酸化チタン、硫酸バリウム
、酸化亜鉛、酸化鉛、ケイ砂、ポリスチレン等の各種の
合成樹脂のほか、多孔質な素材、さらには磁性微粒子が
利用できる。好ましくはアガロース、架橋アガロース、
架橋デキストラン、ポリアクリルアミド、架橋ポリアク
リルアミド、ガラス、シリカゲル、ポリスチレン、セル
ロース、微結晶セルロース等であり、更に好ましくはポ
リアクリルアミド、架橋ポリアクリルアミド、ポリスチ
レン、微結晶セルロース等である。これらの不溶化担体
は数種を混合して用いても良い。抗体又は抗原は、これ
ら不溶化担体に、当業者で公知の方法で化学的及び/又
は物理的に直接、あるいは間接的に結合させることがで
きる。結合法については1976年、講談社発行、千畑
一郎ほか2名編「実験と応用 アフィニティクロマト
グラフィー」(第1刷)、1975年、講談社発行、山
崎 誠ほか2名編「アフィニティクロマトグラフィー
」(第1版)を参考にできる。結合反応後、標識抗体(
又は抗原)の非特異反応を排除する目的で、測定すべき
特異的反応に関与しない蛋白質を担持させることができ
る。それらの代表的な例としては、哺乳動物及び鳥類の
正常血清蛋白質、アルブミン、スキムミルク、乳酸醗酵
物、コラーゲン及びそれらの分解物質等が挙げられる。
尚、非特異吸着抑制蛋白質は、不溶化担体に担持させる
だけでなく、免疫反応時に、その一定量を免疫反応溶液
中に添加することにより、一層非特異吸着の抑制効果が
上がる。[0011] The antibody (or antigen) is immobilized on an insolubilizing carrier. The insolubilizing carrier is a granular material, for example, a size of 2 m.
Particles with a diameter of m or less are preferable. Materials for the insolubilizing carrier (fine particles) include agarose, cellulose, cross-linked dextran, polyacrylamide, cellulose, microcrystalline cellulose, cross-linked agarose, cross-linked polyacrylamide, glass, silica gel, diatomaceous earth, titanium dioxide, barium sulfate, zinc oxide, In addition to various synthetic resins such as lead oxide, silica sand, and polystyrene, porous materials and even magnetic particles can be used. Preferably agarose, cross-linked agarose,
Examples include crosslinked dextran, polyacrylamide, crosslinked polyacrylamide, glass, silica gel, polystyrene, cellulose, microcrystalline cellulose, and more preferably polyacrylamide, crosslinked polyacrylamide, polystyrene, microcrystalline cellulose, and the like. Several types of these insolubilizing carriers may be used in combination. Antibodies or antigens can be chemically and/or physically bound to these insolubilized carriers directly or indirectly by methods known to those skilled in the art. Regarding binding methods, ``Experiments and Applications Affinity Chromatography'' (1st edition) published by Kodansha, 1975, edited by Makoto Yamazaki and 2 authors, published by Kodansha, ``Experiments and Applications Affinity Chromatography'' (1st edition) version) can be used as a reference. After the binding reaction, labeled antibody (
In order to eliminate non-specific reactions (or antigens), proteins that are not involved in the specific reaction to be measured can be supported. Typical examples thereof include normal serum proteins of mammals and birds, albumin, skim milk, lactic acid fermentation products, collagen, and their decomposed substances. In addition, the non-specific adsorption-inhibiting protein is not only supported on the insolubilized carrier, but also added in a certain amount to the immune reaction solution during the immune reaction, thereby further increasing the effect of suppressing non-specific adsorption.
【0012】そして、上記したような固定化抗体(又は
抗原)、酵素標識抗体(又は抗原)及び試料中の抗原(
又は抗体)による免疫反応が容器中で行われた後、この
反応溶液にタバコのフィルターのような毛細管現象を発
揮できる吸水性素材が浸けられると、免疫反応溶液中の
遊離の酵素標識抗体(又は抗原)が吸水性素材側に移行
するようになる。尚、吸水性の素材としては如何なるも
のでも良い。[0012] Then, the above-mentioned immobilized antibody (or antigen), enzyme-labeled antibody (or antigen), and antigen (or antigen) in the sample are
After the immunoreaction with enzyme-labeled antibodies (or antigen) will migrate to the water-absorbing material side. Note that any water-absorbing material may be used.
【0013】この吸水性の素材には分析素子が接合され
ている。尚、図1に示す如く、吸水性素材1と分析素子
2とが予め一体型になったものを免疫反応後の容器3中
に落とし、吸水性素材1を反応溶液4に浸け、毛細管現
象により遊離の酵素標識抗体(又は抗原)が吸水性素材
1側に移行し、さらに分析素子2側に移行した所定時間
後に分析素子2を引き上げると、吸水性素材1は分析素
子2から剥離し、分析素子2だけが引き上げられるよう
なものであったり、図2に示す如く、吸水性素材1を免
疫反応後の反応溶液4に浸け、続いて分析素子2を吸水
性素材1の上に置き、吸水性素材1の毛細管現象により
遊離の酵素標識抗体(又は抗原)が吸水性素材1側に、
さらに分析素子2側に移行した所定時間後に分析素子2
を引き上げられるようにしたものであれば良い。[0013] An analytical element is bonded to this water-absorbing material. As shown in FIG. 1, the water-absorbing material 1 and the analytical element 2 that are integrated in advance are dropped into the container 3 after the immune reaction, and the water-absorbing material 1 is immersed in the reaction solution 4, and the water-absorbing material 1 is immersed in the reaction solution 4, and the water-absorbing material 1 is immersed in the reaction solution 4. When the analytical element 2 is pulled up a predetermined time after the free enzyme-labeled antibody (or antigen) has migrated to the water-absorbent material 1 side and further migrated to the analytical element 2 side, the water-absorbent material 1 is peeled off from the analytical element 2 and analyzed. In some cases, only the element 2 can be lifted up, or as shown in FIG. Due to the capillary action of the absorbent material 1, free enzyme-labeled antibodies (or antigens) are transferred to the water absorbent material 1 side.
Furthermore, after a predetermined period of time after moving to the analytical element 2 side, the analytical element 2
It is fine as long as it is able to raise the
【0014】本発明に用いる分析素子は、少なくとも一
層以上の多孔質層を持つことが好ましい。多孔質層の素
材は特に限定されないが、好ましい例としてはサイズ1
ないし350μmの粒状体あるいは40ないし400メ
ッシュの繊維から一つ以上選ばれた素材により構成され
る構造体が挙げられる。該粒状体の材料としては、ケイ
藻土、二酸化チタン、硫酸バリウム、酸化亜鉛、酸化鉛
、微結晶セルロース、ケイ砂、ガラス、シリカゲル、架
橋デキストリン、架橋ポリアクリルアミド、アガロース
、架橋アガロース、ポリスチレン等の各種の合成樹脂の
ほか、ポリ(スチレン−グリシジルメタクリレート)、
ポリ(スチレン−メチルアクリレート−グリシジルメタ
クリレート)のような反応性基を持つ化合物から成る自
己結合型粒子が挙げられる。The analytical element used in the present invention preferably has at least one porous layer. The material of the porous layer is not particularly limited, but a preferred example is size 1.
Examples include structures made of one or more materials selected from granules of 350 μm to 350 μm or fibers of 40 to 400 mesh. Materials for the granules include diatomaceous earth, titanium dioxide, barium sulfate, zinc oxide, lead oxide, microcrystalline cellulose, silica sand, glass, silica gel, cross-linked dextrin, cross-linked polyacrylamide, agarose, cross-linked agarose, polystyrene, etc. In addition to various synthetic resins, poly(styrene-glycidyl methacrylate),
Examples include self-bonded particles made of compounds with reactive groups such as poly(styrene-methyl acrylate-glycidyl methacrylate).
【0015】又、多孔質層に用いる繊維としては、パル
プ、粉末濾紙、綿、麻、絹、羊毛、キチン、キトサン、
セルロースエステル、ビスコースレーヨン、銅アンモニ
アレーヨン、ポリアミド(6−ナイロン、6,6−ナイ
ロン、6,10−ナイロン等)、ポリエステル(ポリエ
チレンテレフタレート等)、ポリオレフィン(ポリプロ
ピレン、ビニロン等)、ガラス繊維、石綿などの植物性
、動物性、合成、半合成、再生繊維を用いることができ
、あるいはこれらを混合して用いても良い。あるいは別
の態様としては吸水性の洋紙、和紙、濾紙、ブラッシュ
ポリマー、あるいはガラス繊維、鉱物性繊維(石綿など
)、植物性繊維(木綿、麻、パルプ等)、動物性繊維(
羊毛、絹など)、合成繊維(各種ナイロン、ビニロン、
ポリエチレンテレフタレート、ポリプロピレン等)、再
生繊維(レーヨン、セルロースエステル等)などを単独
あるいは混合して製造した織物、不織布、合成紙などを
該多孔質層に用いることもできる。[0015]Fibers used for the porous layer include pulp, powder filter paper, cotton, hemp, silk, wool, chitin, chitosan,
Cellulose ester, viscose rayon, copper ammonia rayon, polyamide (6-nylon, 6,6-nylon, 6,10-nylon, etc.), polyester (polyethylene terephthalate, etc.), polyolefin (polypropylene, vinylon, etc.), glass fiber, asbestos Vegetable, animal, synthetic, semi-synthetic, and regenerated fibers such as fibers may be used, or a mixture of these may be used. Alternatively, water-absorbing Western paper, Japanese paper, filter paper, brushed polymer, glass fiber, mineral fiber (asbestos, etc.), vegetable fiber (cotton, hemp, pulp, etc.), animal fiber (
wool, silk, etc.), synthetic fibers (various nylons, vinylon,
Woven fabrics, nonwoven fabrics, synthetic papers, etc. made of polyethylene terephthalate, polypropylene, etc.), recycled fibers (rayon, cellulose ester, etc.) singly or in combination can also be used for the porous layer.
【0016】このような粒状体、繊維、あるいは粒状体
と繊維の混合物を塗布及び/又は製膜することにより、
自由に接触し得る相互連絡空隙孔を有する多孔性構造が
存在する多孔質層を形成する。自己結合性を有しない粒
子は適当な接着剤を用いて粒子同志が点接着する形で製
膜することができ、例えば特開昭49−53888号公
報、特開昭55−90859号公報、特開昭57−67
860号公報に記載の方法を適用することができる。自
己結合性を有する有機ポリマー粒子は特開昭57−10
1760号公報、特開昭57−101761号公報、特
開昭58−70163号公報に記載の方法により同様に
製膜できる。繊維又は繊維及び粒子の混合物については
特開昭57−125847号公報、特開昭57−197
466号公報に記載された繊維分散液を塗布することに
より多孔質層を形成できる。又、特開昭60−1734
71号公報で行われている方法のようにゼラチンやポリ
ビニルピロリドンのような水溶性バインダーを使用した
繊維分散液を塗布することも可能である。又、このとき
のバインダーは水溶性に限らず、疏水性のバインダーの
使用も可能である。このような分散液を製造する為には
、多くの方法を単独又は組み合わせて用いることが可能
である。例えば、有用な方法の一つとして、界面活性剤
を液体キャリヤーへ添加し、粒状体及び/又は繊維の分
散液中に分布及び安定化を促進することができる。[0016] By applying and/or forming a film from such granules, fibers, or a mixture of granules and fibers,
A porous layer is formed in which there is a porous structure with freely accessible interconnecting pores. Particles that do not have self-bonding properties can be formed into a film by point-adhering the particles to each other using a suitable adhesive. Kaisho 57-67
The method described in Japanese Patent No. 860 can be applied. Organic polymer particles with self-bonding properties are disclosed in Japanese Patent Application Laid-open No. 57-10.
Films can be similarly formed by the methods described in JP-A No. 1760, JP-A-57-101761, and JP-A-58-70163. For fibers or mixtures of fibers and particles, see JP-A-57-125847 and JP-A-57-197.
A porous layer can be formed by applying the fiber dispersion described in Japanese Patent No. 466. Also, JP-A-60-1734
It is also possible to apply a fiber dispersion using a water-soluble binder such as gelatin or polyvinylpyrrolidone, as in the method used in Japanese Patent No. 71. Further, the binder at this time is not limited to a water-soluble one, and a hydrophobic binder can also be used. Many methods can be used alone or in combination to produce such dispersions. For example, one useful method is to add surfactants to the liquid carrier to promote distribution and stabilization within the dispersion of particulates and/or fibers.
【0017】使用可能な代表的な界面活性剤の例として
は、トライトンX−100(ロームアンドハース社製、
オクチルフェノキシポリエトキシエタノール)、サーフ
ァクタント10G(オリーン社製、ノニルフェノキシポ
リグリシドール)等の非イオン性界面活性剤がある。こ
れらの界面活性剤は広範に選択された量を用いることが
可能であるが、粒状体及び/又は繊維の重量に対して0
.005ないし10重量%、好ましくは0.15ないし
6重量%用いることができる。更に、別の方法として、
該粒子単位と液体キャリヤーの音波処理、物理的混合、
及び物理的攪拌処理、pH調整がある。これらは前記の
方法と組み合わせることにより、更に有用である。Examples of typical surfactants that can be used include Triton X-100 (manufactured by Rohm and Haas Co., Ltd.).
There are nonionic surfactants such as octylphenoxypolyethoxyethanol) and Surfactant 10G (manufactured by Orin Co., Ltd., nonylphenoxypolyglycidol). These surfactants can be used in widely selected amounts, but at least 0% based on the weight of the granules and/or fibers.
.. 0.005 to 10% by weight, preferably 0.15 to 6% by weight. Furthermore, as another method,
sonication, physical mixing of the particle units and the liquid carrier;
and physical stirring treatment and pH adjustment. These are even more useful in combination with the methods described above.
【0018】乾式分析素子の形態は分析を行いうるもの
であればよく、特に制限されるものではないが、製造上
及び測定操作上、フィルム状あるいはシート状であるこ
とが好ましい。乾式分析素子は一層から成っていても、
多層から成っていてもよい。例えば、酵素基質を内蔵し
た多孔質層のみからなるものとか、吸水層上に多孔質層
(基質が少なくともどちらかの層に内蔵)が設けられて
なるものとか、吸水層上に複数の多孔質層(基質が少な
くとも何れかの層に内蔵)が設けられてなるものとかが
考えられ、必要に応じて、それらは光透過性支持体上に
設けられたり、光反射性支持体上に設けられたり、光透
過性支持体上に設けられ、その上に光反射性層が設けら
れたりする。The form of the dry analytical element is not particularly limited as long as it can perform analysis, but from the viewpoint of manufacturing and measurement operations, it is preferably in the form of a film or a sheet. Even though a dry analytical element consists of a single layer,
It may also consist of multiple layers. For example, one may consist of only a porous layer containing an enzyme substrate, one may have a porous layer on top of a water absorption layer (the substrate is contained in at least one of the layers), or one may have multiple porous layers on top of a water absorption layer. The substrate may be provided with layers (the substrate is incorporated in at least one of the layers), and if necessary, they may be provided on a light-transmitting support or on a light-reflecting support. Alternatively, it may be provided on a light-transmitting support and a light-reflecting layer may be provided thereon.
【0019】尚、吸水層の素材としては、例えばゼラチ
ン、フタル化ゼラチン等のゼラチン誘導体、ポリビニル
アルコール、ポリビニルピロリドン、ポリビニルイミダ
ゾール、ポリアクリルアミド、ポリアクリル酸ナトリウ
ム等の合成高分子、ヒドロキシエチルセルロース、カル
ボキシメチルセルロースナトリウム塩などのセルロース
誘導体の多糖類などが挙げられる。好ましくは、ゼラチ
ン、フタル化ゼラチン等のゼラチン誘導体である。Examples of materials for the water absorption layer include gelatin, gelatin derivatives such as phthalated gelatin, synthetic polymers such as polyvinyl alcohol, polyvinylpyrrolidone, polyvinylimidazole, polyacrylamide, and sodium polyacrylate, hydroxyethyl cellulose, and carboxymethyl cellulose. Examples include polysaccharides of cellulose derivatives such as sodium salts. Preferred are gelatin derivatives such as gelatin and phthalated gelatin.
【0020】光透過性支持体の素材としては、例えば酢
酸セルロース、ポリエチレンテレフタレート、ポリカー
ボネート及びホリビニル化合物(例えばポリスチレン)
のような透明高分子化合物あるいはガラスのような透明
無機化合物が挙げられる。光反射性支持体の素材として
は、例えばセラミックス、金属、あるいは樹脂被覆され
た紙などが挙げられ、必要に応じてこれらの素材中には
TiO2 、BaSO4 、マイカなどの白色顔料など
を含有又は塗布させたものでも良い。Materials for the light-transmitting support include, for example, cellulose acetate, polyethylene terephthalate, polycarbonate, and polyvinyl compounds (such as polystyrene).
Examples include transparent polymer compounds such as , and transparent inorganic compounds such as glass. Materials for the light-reflective support include, for example, ceramics, metals, or resin-coated paper, and if necessary, these materials may contain or be coated with white pigments such as TiO2, BaSO4, or mica. It's okay to let them do it.
【0021】そして、例えば光透過性支持体上に基質を
内蔵した多孔質層が設けられてなる乾式分析素子が用い
られる場合には、免疫反応溶液中に浸けられた吸水性素
材に対して乾式分析素子の多孔質層側が接合され、吸水
性素材を介して遊離の酵素標識抗体(又は抗原)が乾式
分析素子の多孔質層に移行することから、これによる発
色信号の測定が両側から行われる。又、光反射性支持体
上に基質を内蔵した多孔質層が設けられてなる乾式分析
素子が用いられる場合には、免疫反応溶液中に浸けられ
た吸水性素材に対して乾式分析素子の多孔質層側が接合
され、吸水性素材を介して遊離の酵素標識抗体(又は抗
原)が乾式分析素子の多孔質層に移行することから、信
号の測定は多孔質層側から行われる。尚、光透過性支持
体上に基質を内蔵した多孔質層が設けられ、その上に光
反射性層が設けられてなる乾式分析素子が用いられる場
合には、吸水性素材は光反射性層側に接合がなされ、信
号の測定は光透過性支持体側から行われる。[0021] For example, when a dry analytical element is used, in which a porous layer containing a substrate is provided on a light-transmitting support, a dry analytical element is applied to the water-absorbing material immersed in the immunoreaction solution. The porous layer side of the analytical element is bonded, and the free enzyme-labeled antibody (or antigen) migrates to the porous layer of the dry analytical element through the water-absorbing material, so that color signals are measured from both sides. . In addition, when a dry analytical element is used, in which a porous layer containing a substrate is provided on a light-reflective support, the pores of the dry analytical element are Since the dry layer side is joined and the free enzyme-labeled antibody (or antigen) is transferred to the porous layer of the dry analytical element via the water-absorbing material, signal measurement is performed from the porous layer side. In addition, when a dry analytical element is used in which a porous layer containing a substrate is provided on a light-transmitting support and a light-reflecting layer is provided on top of the porous layer, the water-absorbing material is the light-reflecting layer. The sides are bonded and the signal is measured from the side of the light-transparent support.
【0022】標識に起因した信号は、紫外線、可視光、
近赤外光などを利用した吸光度法(比色法) などで検
出することができ、測定法としては信号の経時的変化を
測定するレート測定法または一定時間後の信号を測定す
るエンドポイント測定法で測定することができる。乾式
分析素子は、展開層を有するものであっても良い。展開
層の素材としては、多孔質層と同様なものを塗布、製膜
、貼付しても良い。又、展開層内に基質等を内蔵させ、
反応層としての役目を持たせても良い。乾式分析素子に
は、他の添加剤、例えば緩衝剤、保恒剤、界面活性剤、
媒染剤等を目的に応じて添加することができる。緩衝剤
は、特異的結合反応、酵素反応、発色反応等に適したp
Hとする為に含有される。用いることができる緩衝剤と
しては日本化学会編「化学便覧基礎編」(東京、丸善株
式会社 1966)pp1312ないし1320、N
.E.Good等; Biochemistry V
ol 5、p467(1966)、今村、斎藤; 化
学の領域、Vol30(2)、p79(1976)、W
.J.Ferguson等 Anal.Bioche
m.Vol 104、p300(1980)等の文献
に記載されているものを挙げることができる。具体的な
例としては、ホウ酸塩、クエン酸塩、燐酸塩、炭酸塩、
トリスバルビツール、グリシン、グッド緩衝剤などが挙
げられる。これらの緩衝剤は必要に応じて単独で層を形
成させてもよい。保恒剤は基質発色試薬の保存安定化の
為に含有され、酸化防止剤などがある。その物質として
は、日本生化学会編「生化学実験口座1、蛋白質の化学
1」(東京化学同人株式会社 1976) pp66
,67、実験と応用「アフィニティクロマトグラフィ」
pp16ないし104、特開昭60−149927号公
報などに記載されているものが挙げられる。具体的例と
しては、ゼラチン、ゼラチン分解物、アルブミン、シク
ロデキストリン類、非還元糖類(シュクロース、トレハ
ロース)、ポリエチレングリコール、アミノ酸、各種イ
オン、アジ化ソーダ等が挙げられる。界面活性剤として
は、前述のものが挙げられる。その他の層中に含有され
る試薬としては、溶解助剤、ブロッカー試薬などがある
。これらの添加剤は必要に応じて適当量添加する。媒染
剤は、酵素活性測定の為の検出物質を測光部側に集中的
に集めたり、検出物質が色素の場合吸光度係数を高めた
り、波長をシフトさせる物質であり、検出物質と強い相
互作用を示す。カチオン性ポリマー、アニオン性ポリマ
ー及びこれらのポリマーのラテックスが用いられる。乾
式分析素子は、さらに生体試料が血液(全血)の場合に
有用な血球分離層、必要に応じて設ける接着層、保護層
、タイミング層といった補助層を設けることができる。
これらの層は、その機能に応じて設けられるべき位置が
決定される。[0022] Signals caused by labels include ultraviolet light, visible light,
It can be detected by absorbance method (colorimetric method) using near-infrared light, etc., and measurement methods include rate measurement method that measures changes in the signal over time or end point measurement that measures the signal after a certain period of time. It can be measured by the method. The dry analytical element may have a spreading layer. As the material for the spreading layer, the same material as that for the porous layer may be applied, formed into a film, or attached. In addition, by incorporating a substrate etc. into the developing layer,
It may also serve as a reaction layer. Dry analytical elements may contain other additives such as buffers, preservatives, surfactants,
A mordant or the like can be added depending on the purpose. The buffer is a pH suitable for specific binding reactions, enzymatic reactions, color reactions, etc.
Contained to make H. Buffers that can be used include "Chemical Handbook Basic Edition" edited by the Chemical Society of Japan (Tokyo, Maruzen Co., Ltd. 1966) pp1312-1320, N
.. E. Good et al; Biochemistry V
ol 5, p467 (1966), Imamura, Saito; Chemistry Area, Vol 30 (2), p79 (1976), W
.. J. Ferguson et al. Anal. Bioche
m. Examples include those described in literature such as Vol 104, p300 (1980). Specific examples include borates, citrates, phosphates, carbonates,
Examples include trisbarbiturate, glycine, and Good's buffer. These buffering agents may be used alone to form a layer, if necessary. Preservatives are included to stabilize the storage of the substrate coloring reagent, and include antioxidants and the like. The substance is described in "Biochemistry Experiment Account 1, Protein Chemistry 1" edited by the Japanese Biochemical Society (Tokyo Kagaku Doujin Co., Ltd. 1976) pp66
, 67, Experiments and Applications "Affinity Chromatography"
Examples include those described in pp. 16 to 104, JP-A-60-149927, and the like. Specific examples include gelatin, gelatin decomposition products, albumin, cyclodextrins, non-reducing sugars (sucrose, trehalose), polyethylene glycol, amino acids, various ions, sodium azide, and the like. Examples of the surfactant include those mentioned above. Other reagents contained in the layer include solubilizers, blocker reagents, and the like. These additives are added in appropriate amounts as necessary. A mordant is a substance that concentrates the detection substance for enzyme activity measurement on the photometer side, increases the absorbance coefficient when the detection substance is a dye, or shifts the wavelength, and exhibits strong interaction with the detection substance. . Cationic polymers, anionic polymers and latexes of these polymers are used. The dry analytical element can further be provided with auxiliary layers such as a blood cell separation layer useful when the biological sample is blood (whole blood), an adhesive layer, a protective layer, and a timing layer provided as necessary. The positions of these layers are determined according to their functions.
【0023】[0023]
【実施例】以下、本発明を実施例によって更に具体的に
説明するが、本発明はこれら実施例によって限定される
ものではない。
1−(1) β−D−ガラクトシダーゼ標識CRP抗
体の作成
CRP抗体(ウサギIgGフラクション、タウンズ社製
)20mgを0.1Mのリン酸緩衝液(p6.5)2.
0mlに溶解し、これにN−(ε−マレイミドカプロイ
ルオキシ)スクシンイミド(同仁化学研究所製)が2.
5mg/mlのジメチルホルムアミド溶液77μlを加
えて、30℃で20分間反応後、5mMのEDTAを含
有する0.1Mのリン酸緩衝液(pH6.0)で平衡化
したセファデックスG−25カラムで精製し、マレイミ
ド化したCRP抗体を得た。EXAMPLES The present invention will be explained in more detail below with reference to Examples, but the present invention is not limited to these Examples. 1-(1) Preparation of β-D-galactosidase-labeled CRP antibody 20 mg of CRP antibody (rabbit IgG fraction, manufactured by Townes) was dissolved in 0.1 M phosphate buffer (p6.5)2.
0 ml of N-(ε-maleimidocaproyloxy)succinimide (manufactured by Dojindo Laboratories).
After adding 77 μl of 5 mg/ml dimethylformamide solution and reacting at 30°C for 20 minutes, it was applied to a Sephadex G-25 column equilibrated with 0.1 M phosphate buffer (pH 6.0) containing 5 mM EDTA. A purified and maleimidated CRP antibody was obtained.
【0024】次に、β−D−ガラクトシダーゼ(東洋紡
社製)が10.5mg/mlの0.1Mリン酸緩衝液1
.8mlに、前記マレイミド化したCRP抗体を13.
6mg含む溶液3.2mlを加えて、4℃で45時間反
応後、0.1Mの2−メルカプトエチルアミン175μ
lを加えて30℃で20分間反応させ、0.15Mの塩
化ナトリウムを含有する0.1Mリン酸緩衝液(pH7
.4)で平衡化したスーパーローズ6プレップグレード
(ファルマシア社製)カラムで分離、精製し、β−D−
ガラクトシダーゼ標識CRP抗体を得た。Next, β-D-galactosidase (manufactured by Toyobo) was added to 0.1M phosphate buffer solution 1 containing 10.5 mg/ml.
.. 13. Add the maleimidated CRP antibody to 8 ml.
Add 3.2 ml of a solution containing 6 mg and react at 4°C for 45 hours, then add 175 μ of 0.1 M 2-mercaptoethylamine.
1 was added and reacted at 30°C for 20 minutes, and then diluted with 0.1M phosphate buffer (pH 7
.. 4) was separated and purified using a Superrose 6 prep grade (manufactured by Pharmacia) column, and β-D-
A galactosidase-labeled CRP antibody was obtained.
【0025】1−(2) CRP抗体固定化オイパー
ギットCの合成
オイパーギットC(ロームファーマ社製)3gを0.1
5Mの塩化ナトリウムを含有する0.1Mリン酸緩衝液
(pH8.0)40ml中に分散し、これにCRP抗体
(ウサギIgGフラクション、タウンズ社製)136m
gを入れ、4℃で20時間攪拌し反応させる。反応後、
濾取し、0.1M酢酸緩衝液(pH4.0)と0.1M
の炭酸緩衝液(pH8.0)を交互に用い、充分洗浄し
た。1-(2) Synthesis of CRP antibody-immobilized Eupergit C 3 g of Eupergit C (manufactured by Rohm Pharma) was mixed with 0.1
It was dispersed in 40 ml of 0.1 M phosphate buffer (pH 8.0) containing 5 M sodium chloride, and 136 ml of CRP antibody (rabbit IgG fraction, manufactured by Townes) was added to it.
g and stirred at 4°C for 20 hours to react. After the reaction,
Collected by filtration, mixed with 0.1M acetate buffer (pH 4.0) and 0.1M
The carbonate buffer solution (pH 8.0) was used alternately to wash thoroughly.
【0026】次いで、水洗した後、経口38μmのメッ
シュでふるいをかけた。オイパーギットCの非特異的結
合部位をブロックする為、上記のふるいをかけたオイパ
ーギットCを3%脱脂乳添加の0.1Mのビストリス緩
衝液(pH7.2)50ml中で4℃、20時間攪拌し
た。次いで水洗し、CRP抗体固定化オイパーギットC
を得た。[0026] After washing with water, the mixture was sieved through a 38 μm mesh. In order to block non-specific binding sites of Eupergit C, the sieved Eupergit C was stirred in 50 ml of 0.1 M Bis Tris buffer (pH 7.2) supplemented with 3% skim milk at 4°C for 20 hours. . Then, it was washed with water, and CRP antibody-immobilized Eupergit C was added.
I got it.
【0027】1−(3) 乾式分析素子の作成厚さ1
80μmの透明な下引き済ポリエチレンテレフタレート
フィルムの上に、下記の組成の塗布液(1)を塗布し、
乾燥させ、ゼラチン層を作成させた。
塗布液−(1)
脱イオン化ゼラチン
6.0g トライ
トンX−100
0.15g 1,2−ビス(ビニル
スルホニル)エタン 0.01g 純
水
54.0g次に、塗布液
−(2)を前記ゼラチン層の上に塗布し、乾燥した。1-(3) Creation thickness of dry analytical element 1
Coating solution (1) with the following composition was applied onto a transparent subbed polyethylene terephthalate film of 80 μm,
It was dried to form a gelatin layer. Coating liquid - (1) Deionized gelatin
6.0g Triton X-100
0.15g 1,2-bis(vinylsulfonyl)ethane 0.01g Pure water
54.0 g Next, coating liquid (2) was applied onto the gelatin layer and dried.
【0028】
塗布液−(2)
粉末ろ紙C(東洋濾紙社製)
21.6g ピロリドン−酢酸
ビニル(2対8)共重合体 11.0g クロ
ロフェニルレッドβ−D−ガラクトピラノシド(ベーリ
ンガー社製)
365mg n−ブタノール
49.4
gこれを1.5cm×1.5cmの大きさに裁断し、乾
式分析素子とし、この乾式分析素子の上に図1に示す如
く円柱形状(径5mm、高さ10mm)のパルプ体を接
着した。Coating liquid-(2) Powder filter paper C (manufactured by Toyo Roshi Co., Ltd.)
21.6g Pyrrolidone-vinyl acetate (2:8) copolymer 11.0g Chlorophenyl red β-D-galactopyranoside (manufactured by Boehringer)
365mg n-butanol
49.4
g This was cut into a size of 1.5 cm x 1.5 cm to form a dry analysis element, and a cylindrical pulp body (diameter 5 mm, height 10 mm) was glued onto this dry analysis element as shown in Figure 1. .
【0029】1−(4) CRPの測定1mMのMg
Cl2 及び3%のBSAを含む0.5Mビストリス緩
衝液190mlに抗CRP固定化オイパーギットC15
mg、β−D−ガラクトシダーゼ標識CRP抗体(20
μg/ml)25μl及びCRP溶液(0.3、10、
30、100、300μg/ml)7μlを添加混合し
、室温下で12分間免疫反応させる。反応後、乾式分析
素子の円柱形状のパルプ体を反応液中に浸け、5秒後に
乾式分析素子を持ち上げ、これを37℃でインキュベー
トしながら546nmの反射濃度を測定した。3分30
秒ないし7分の反射濃度差(△Dr)を用いて検量線を
作成した結果を図3に示す。1-(4) Measurement of CRP 1mM Mg
Anti-CRP immobilized Eupergit C15 in 190 ml of 0.5 M Bis Tris buffer containing Cl2 and 3% BSA.
mg, β-D-galactosidase labeled CRP antibody (20
25 μl of μg/ml) and CRP solution (0.3, 10,
Add 7 μl of 30, 100, 300 μg/ml), mix, and allow immunoreaction for 12 minutes at room temperature. After the reaction, the cylindrical pulp of the dry analytical element was immersed in the reaction solution, and after 5 seconds, the dry analytical element was lifted and the reflection density at 546 nm was measured while incubating it at 37°C. 3 minutes 30
FIG. 3 shows the results of creating a calibration curve using the reflection density difference (ΔDr) from seconds to seven minutes.
【0030】これによればCRPが正確に測定されるこ
とが判り、又、測定は反応液中に吸水性素材及び分析素
子を落とすだけの手軽な作業で行える。すなわち、バッ
クグラウンドノイズは小さく、CRPが正確に測定でき
るものであり、かつ、B/F分離の為の特別な操作や液
の移し換えの操作をせずとも測定が行える。[0030] According to this method, it has been found that CRP can be measured accurately, and the measurement can be carried out simply by dropping the water-absorbing material and the analytical element into the reaction solution. That is, the background noise is small, CRP can be measured accurately, and the measurement can be performed without any special operation for B/F separation or liquid transfer operation.
【図1】本発明の免疫学的測定法を示す概略図である。FIG. 1 is a schematic diagram showing the immunoassay method of the present invention.
【図2】本発明の免疫学的測定法を示す概略図である。FIG. 2 is a schematic diagram showing the immunoassay method of the present invention.
【図3】検量線を示すグラフである。FIG. 3 is a graph showing a calibration curve.
Claims (2)
容器中の反応液に毛細管現象を発揮できる吸水性素材を
浸け、この吸水性素材を介して標識体を吸水性素材に接
合された分析素子に移行させ、標識体を分析素子で測定
することにより試料中の特定成分を分析することを特徴
とする免疫学的測定法。Claim 1: After an immune reaction is carried out in a container, a water-absorbing material capable of exhibiting capillary action is immersed in the reaction solution in the container, and the label is bonded to the water-absorbing material via this water-absorbing material. An immunoassay method characterized in that a specific component in a sample is analyzed by transferring the labeled substance to an analytical element and measuring the labeled substance with the analytical element.
(又は抗原)、酵素標識抗体(又は抗原)及び試料中の
抗原(又は抗体)による免疫反応を容器中で行わせた後
、分析素子と接合された吸水性素材を反応液に浸け、吸
水性素材の毛細管現象により遊離の酵素標識抗体(又は
抗原)を分析素子に移行させ、その後前記分析素子を取
り、標識酵素を分析素子で測定することにより試料中の
抗原(又は抗体)を分析することを特徴とする免疫学的
測定法。2. After performing an immune reaction in a container with the immobilized antibody (or antigen) immobilized on the immobilization carrier, the enzyme-labeled antibody (or antigen), and the antigen (or antibody) in the sample, analysis is performed. The water-absorbent material bonded to the element is immersed in the reaction solution, and the free enzyme-labeled antibody (or antigen) is transferred to the analytical element by capillary action of the water-absorbent material.Then, the analytical element is removed, and the labeled enzyme is transferred to the analytical element. An immunoassay method characterized by analyzing antigens (or antibodies) in a sample by measuring.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6712891A JPH04301765A (en) | 1991-03-29 | 1991-03-29 | Immunological measuring method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6712891A JPH04301765A (en) | 1991-03-29 | 1991-03-29 | Immunological measuring method |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04301765A true JPH04301765A (en) | 1992-10-26 |
Family
ID=13335958
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6712891A Pending JPH04301765A (en) | 1991-03-29 | 1991-03-29 | Immunological measuring method |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04301765A (en) |
-
1991
- 1991-03-29 JP JP6712891A patent/JPH04301765A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4868106A (en) | Analytical element and method for determining a component in a test sample | |
US4948726A (en) | Enzyme immunoassay based on membrane separation of antigen-antibody complexes | |
JPS61292060A (en) | Analyzing element | |
EP0297292A2 (en) | Method and test device for separating labeled reagent in an immunometric binding assay | |
US5266460A (en) | Method of preparing immunological analytical element | |
EP0579250B1 (en) | Homogeneous immunoassay, enzyme-labelled antibody and element | |
JPS5915861A (en) | Material for immune analysis | |
JPH0772152A (en) | Specific binding assay method and element of analysis | |
JPH0510951A (en) | Immunological measuring device | |
JPH04301765A (en) | Immunological measuring method | |
JPH052021A (en) | Immunoreactive apparatus and immunological measuring apparatus and method | |
EP0517338A2 (en) | Analytical element coated by a gravure process | |
JPH04351963A (en) | Immunological measurement device and method thereof | |
JPH04357457A (en) | Immunological measurement method | |
JPH04113270A (en) | Immunity detecting method | |
EP0740157A2 (en) | Immunoassay element comprising both labeled ligand and receptors | |
JPH04186158A (en) | Immunity measuring method | |
JPH04315960A (en) | Method for analyzing and measuring immunity | |
JPH04369476A (en) | Immunoreaction element and immunoassay | |
JPH0672884B2 (en) | Analytical element | |
JPH05126831A (en) | Immunoassay element and immunoassay method | |
JPH04113269A (en) | Immunity detecting method | |
JPH04303769A (en) | Device and method for immunological measurement | |
JPH04186159A (en) | Immunity measuring method | |
JPH0545360A (en) | Immunological measuring apparatus |